Former Neogen Corporation director Thierry Bernard filed a Form 144 notice on October 28, 2026, disclosing a proposed sale of 16,937 shares of Neogen common stock acquired through a stock option exercise.

Key Highlights

  • Seller: Thierry Bernard, identified in the filing as a former director of Neogen Corporation.
  • Shares proposed for sale: 16,937 shares of Neogen common stock, with an aggregate market value of $206,520.92.
  • Acquisition method: Shares were acquired on October 28, 2026, via a stock option exercise from the issuer, with cash payment on the same date.
  • Shares outstanding: 218,306,034 shares of Neogen common stock outstanding, according to the filing.
  • Broker: Fidelity Brokerage Services LLC, 900 Salem Street, Smithfield, RI 02917, is named as the broker for the proposed sale.
  • Prior sales: The filing reports nothing to report for securities sold during the past three months.
  • Exchange: Shares trade on NASDAQ, consistent with the filing's securities information section.

Neogen Former Director Discloses Proposed Rule 144 Stock Sale

According to the Form 144 notice filed with the U.S. Securities and Exchange Commission, Thierry Bernard, identified as a former director of Neogen Corporation (NASDAQ:NEOG), proposed to sell 16,937 shares of the company's common stock on or around October 28, 2026. The aggregate market value of those shares was listed as $206,520.92 in the filing. The notice was signed by Gary Redman as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Thierry Bernard.

The filing indicates that all 16,937 shares were acquired on October 28, 2026, through a stock option exercise from the issuer, with payment made in cash on the same date. The Form 144 is a notice of proposed sale under Rule 144 of the Securities Act of 1933, which governs resales of restricted or control securities. The filing disclosed that Neogen had approximately 218,306,034 shares of common stock outstanding as of the notice date.

The filing further states that no securities of the issuer were sold by Bernard during the three months preceding this notice. The signatory represented, consistent with Form 144 requirements, that the person for whose account the securities are to be sold does not know any material adverse information regarding the current and prospective operations of the issuer that has not been publicly disclosed.

What Was Disclosed

Thierry Bernard, a former Neogen Corporation director, filed a Form 144 notice on October 28, 2026, proposing to sell 16,937 shares of Neogen common stock with an aggregate market value of $206,520.92, acquired the same day via stock option exercise.